These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12397859

  • 1. Pharmacokinetically induced benzodiazepine withdrawal.
    Ninan PT.
    Psychopharmacol Bull; 2001; 35(4):94-100. PubMed ID: 12397859
    [Abstract] [Full Text] [Related]

  • 2. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [Abstract] [Full Text] [Related]

  • 3. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR, Nemeroff CB.
    Depress Anxiety; 1998 Oct; 7 Suppl 1():24-32. PubMed ID: 9597349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of venlafaxine on the pharmacokinetics of alprazolam.
    Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM.
    Psychopharmacol Bull; 1998 Oct; 34(2):211-9. PubMed ID: 9641003
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam withdrawal delirium: a case report.
    Zalsman G, Hermesh H, Munitz H.
    Clin Neuropharmacol; 1998 Oct; 21(3):201-2. PubMed ID: 9617514
    [Abstract] [Full Text] [Related]

  • 9. Topiramate use in alprazolam addiction.
    Michopoulos I, Douzenis A, Christodoulou C, Lykouras L.
    World J Biol Psychiatry; 2006 Oct; 7(4):265-7. PubMed ID: 17071548
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
    Hall J, Naranjo CA, Sproule BA, Herrmann N.
    J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410
    [Abstract] [Full Text] [Related]

  • 11. Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
    Ketter TA, Callahan AM, Post R.
    J Clin Psychiatry; 1996 Jul; 57(7):307. PubMed ID: 8666573
    [No Abstract] [Full Text] [Related]

  • 12. Re: Nefazodone withdrawal symptoms.
    Markowitz JS.
    Can J Psychiatry; 1999 Apr; 44(3):286-7. PubMed ID: 10225136
    [No Abstract] [Full Text] [Related]

  • 13. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
    Olyaei AJ, deMattos AM, Norman DJ, Bennett WM.
    Pharmacotherapy; 1998 Apr; 18(6):1356-9. PubMed ID: 9855339
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discontinuation symptoms with nefazodone.
    Rajagopalan M, Little J.
    Aust N Z J Psychiatry; 1999 Aug; 33(4):594-7. PubMed ID: 10483857
    [Abstract] [Full Text] [Related]

  • 16. Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Haney M, Hart CL, Ward AS, Foltin RW.
    Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E.
    J Clin Psychiatry; 2002 Jan; 63 Suppl 14():27-33. PubMed ID: 12562116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH.
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.